Alison Rebman, MPH

• Co-Director of Clinical and Epidemiological Research, Lyme Disease Research Center

Assistant Professor of Medicine

Lyme Disease Clinical Research Center

Acute and post-treatment Lyme disease, Illness experience of medically contested conditions, Sex and gender-based differences in health

Alison Rebman is currently engaged in both quantitative and qualitative research that seeks to understand the epidemiology, risk factors, and patient illness experience of post-treatment Lyme disease. 

https://www.ncbi.nlm.nih.gov/myncbi/alison.rebman.1/bibliography/public/

• Rebman AW, Aucott JN, Weinstein ER, Bechtold KT, Smith KC, Leonard L. Living in limbo: contested narratives of patients with chronic symptoms following Lyme disease. Qual Health Res. 2017:27(4):534-546. PMID: 26631681

• Rebman AW, Bechtold KT, Yang T, Mihm EA, Soloski MJ, Novak CB, Aucott JN. The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with post-treatment Lyme disease syndrome. Front Med (Lausanne). 2017:4:224. PMCID: PMC5735370

• Rebman AW, Wang L, Yang T, Marsteller JA, Murphy SME, Uriyo M, Mihm EA, Weinstein ER, Fagan P, Aucott JN. Incidence of Lyme disease diagnosis in a Maryland Medicaid population (2004-2011). Am J Epidemiol. 2018:187(10):2202-2209. PMID: 29955850

• Aucott JN, Rebman AW. Long-haul COVID: heed the lessons from other infection-triggered illnesses. The Lancet. 2021:397(10278):967-968. PMCID: PMC7952095

• Aucott JN, Yang T, Yoon I, Powell D, Geller SA, Rebman AW. Risk of post-treatment Lyme disease in patients with ideally treated Lyme disease: A prospective cohort study. IJID 2022:116;230-237. PMID: 35066160